女性绝经前后认知功能的变化研究进展
董建业 陈友国^*

苏州大学附属第一医院，江苏苏州，215006；

摘要：绝经是女性生命中的重要生理转折点，主要表现在卵巢功能衰退和雌激素水平的显著下降。这一过程不仅影响女性生殖系统，也影响着中枢神经系统功能。流行病学显示绝经后女性认知衰退风险增加。这一现象背后的机制及干预措施有待研究。本文围绕有关女性绝经前后认知功能的变化的相关研究进行综述，以期为改善女性绝经后认知功能的下降提供科学依据和指导。

关键词：女性；绝经；认知功能；激素替代治疗

参考文献

[1]DAVIS S R, PINKERTON J, SANTORO N, et al. Menopause-Biology, consequences, supportive care, and therapeutic options [J]. Cell, 2023, 186(19): 4038-58.

[2]MAHBOOBIFARD F, POURGHOLAMI M H, JORJANI M, et al. Estrogen as a key regulator of energy homeostasis and metabolic health [J].Biomedicine & pharmacotherapy= Biomedecine & pharmacotherapie, 2022, 156: 113808.

[3]MANGIONE C M, BARRY M J, NICHOLSON W K, et al. Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Persons: US Preventive Services Task Force Recommendation Statement [J].Jama,2022,328(17):1740-6.

[4]SRIVASTAVA D P, WOOLFREY K M, PENZES P. Insights into rapid modulation of neuroplasticity by brain estrogens [J]. Pharmacological reviews, 2013, 65(4): 1318-50.

[5]DELEVICH K, PIEKARSKI D, WILBRECHT L. Neuroscience: Sex Hormones at Work in the Neocortex[J].Current biology:CB,2019,29(4):R122-r5.

[6]KHAN I, SAEED K, JO M G, et al. 17-beta Estradiol Rescued Immature Rat Brain against Glutamate-Induced Oxidative Stress and Neurodegeneration via Regulating Nrf2/HO-1 and MAP-Kinase Signaling Pathway [J]. Antioxidants (Basel, Switzerland), 2021, 10(6).

[7]KIRSHNER Z Z, YAO J K, LI J, et al. Impact of estrogen receptor agonists and model of menopause on enzymes involved in brain metabolism, acetyl-CoA production and cholinergic function [J]. Life sciences, 2020, 256: 117975.

[8]EMRANI S, SUNDERMANN E E. Sex/gender differences in the clinical trajectory of Alzheimer's disease: Insights into diagnosis and cognitive reserve [J]. Frontiers in neuroendocrinology, 2025, 77: 101184.

[9]DEVI G. Menopause-Related Cognitive Impairment [J]. Obstetrics and gynecology, 2018, 132(6): 1325-7.

[10]DANIEL J M, LINDSEY S H, MOSTANY R, et al. Cardiometabolic health, menopausal estrogen therapy and the brain: How effects of estrogens diverge in healthy and unhealthy preclinical models of aging [J]. Frontiers in neuroendocrinology, 2023, 70: 101068.

[11]LIU K, LEI X, ZHAO L, et al. Cognitive shadows in perimenopause: linking subjective cognitive decline (SCD) to menopausal symptom severity [J]. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2024, 40(1): 2352134.

[12]KUH D, COOPER R, MOORE A, et al. Age at menopause and lifetime cognition: Findings from a British birth cohort study [J]. Neurology, 2018, 90(19): e1673-e81.

[13]METCALF C A, DUFFY K A, PAGE C E, et al. Cognitive Problems in Perimenopause: A Review of Recent Evidence [J]. Current psychiatry reports, 2023, 25(10): 501-11.

[14]GUO M, WU Y, GROSS A L, et al. Age at menopause and cognitive function and decline among middle-aged and older women in the China Health and Retirement Longitudinal Study, 2011-2018 [J]. Alzheimers Dement, 2025, 21(2): e14580.

[15]GEORGAKIS M K, BESKOU-KONTOU T, THEODORIDIS I, et al. Surgical menopause in association with cognitive function and risk of dementia: A systematic review and meta-analysis [J]. Psychoneuroendocrinology, 2019, 106: 9-19.

[16]LIAO H, CHENG J, PAN D, et al. Association of earlier age at menopause with risk of incident dementia, brain structural indices and the potential mediators: a prospective community-based cohort study [J]. EClinicalMedicine, 2023, 60: 102033.

[17]RAVINDRANATH V. Srinivaspura Aging, Neuro Senescence and COGnition (SANSCOG) study: Study protocol [J]. Alzheimer's & Dementia: the Journal of the Alzheimer's Association, 2023, 19(6): 2450-9.

[18]TSAI J H, HUANG C F, LIN M N, et al. Taiwanese Vegetarians Are Associated with Lower Dementia Risk: A Prospective Cohort Study [J]. Nutrients, 2022, 14(3).

[19]PEMBERTON K, ROSATO M, DEDERT C, et al. Differential Effects of the G-Protein-Coupled Estrogen Receptor (GPER) on Rat Embryonic (E18) Hippocampal and Cortical Neurons [J]. eNeuro, 2022, 9(4).

[20]YOON E J, CHOI Y, PARK D. Improvement of Cognitive Function in Ovariectomized Rats by Human Neural Stem Cells Overexpressing Choline Acetyltransferase via Secretion of NGF and BDNF [J]. Int J Mol Sci, 2022, 23(10).

[21]MISHRA P, DAVIES D A, ALBENSI B C. The Interaction Between NF-kappaB and Estrogen in Alzheimer's Disease [J]. Molecular neurobiology, 2023, 60(3): 1515-26.

[22]EKANAYAKE A, PEIRIS S, AHMED B, et al. A Review of the Role of Estrogens in Olfaction, Sleep and Glymphatic Functionality in Relation to Sex Disparity in Alzheimer's Disease [J]. American journal of Alzheimer's disease and other dementias, 2024, 39: 15333175241272025.

[23]RISHABH, ROHILLA M, BANSAL S, et al. Estrogen signalling and Alzheimer's disease: Decoding molecular mechanisms for therapeutic breakthrough [J]. The European journal of neuroscience, 2024, 60(1): 3466-90.

[24]SOCHOCKA M, KARSKA J, PSZCZOLOWSKA M, et al. Cognitive Decline in Early and Premature Menopause [J]. Int J Mol Sci, 2023, 24(7).

[25]KIPINOINEN T, TOPPALA S, RINNE J O, et al. Association of Midlife Inflammatory Markers With Cognitive Performance at 10-Year Follow-up [J]. Neurology, 2022, 99(20): e2294-e302.

[26]ZHANG Y, PENG Y, DENG W, et al. Association between dietary inflammatory index and cognitive impairment among American elderly: a cross-sectional study [J]. Front Aging Neurosci, 2024, 16: 1371873.

[27]GUO X, LIU R, JIA M, et al. Ischemia Reperfusion Injury Induced Blood Brain Barrier Dysfunction and the Involved Molecular Mechanism [J]. Neurochem Res, 2023, 48(8): 2320-34.

[28]ZHAO W, HOU Y, ZHANG Q, et al. Estrogen receptor beta exerts neuroprotective effects by fine-tuning mitochondrial homeostasis through NRF1/PGC-1alpha [J]. Neurochemistry international, 2023: 105636.

[29]ITOH N, ITOH Y, MEYER C E, et al. Estrogen receptor beta in astrocytes modulates cognitive function in mid-age female mice [J]. Nature communications, 2023, 14(1): 6044.

[30]RAMLI N Z, YAHAYA M F, MOHD FAHAMI N A, et al. Brain volumetric changes in menopausal women and its association with cognitive function: a structured review [J]. Front Aging Neurosci, 2023, 15: 1158001.

[31]WU J G, ZHAO P, YANG J, et al. Activation of Follicle-Stimulating Hormone Receptor in Adrenal Zona Fasciculata Cells Promotes Cortisol Secretion: Implications for the Development of Menopause-Associated Diseases [J]. Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 2025, 133(1): 8-19.

[32]KHAIRY E Y, SALAMA O A. Effect of exercise on the hypothalamic-pituitary-gonadal axis in a rat model of Alzheimer's disease [J]. Sci Rep, 2023, 13(1): 14300.

[33]MA J, GUO C Y, LI H B, et al. Prophylactic Effects of Hemp Seed Oil on Perimenopausal Depression: A Role of HPA Axis [J]. Journal of oleo science, 2023, 72(10): 939-55.

[34]ZHONG X, SUN Y, LU Y, et al. Immunomodulatory role of estrogen in ischemic stroke: neuroinflammation and effect of sex [J]. Frontiers in immunology, 2023, 14: 1164258.

[35]SKINNER B D, WEAVER S R C, LUCAS S J E, et al. Menstrual phase influences cerebrovascular responsiveness in females but may not affect sex differences [J]. Frontiers in physiology, 2022, 13: 1035452.

[36]BAO H, ZHENG S, SHEN Y. Sexual dimorphism in cerebrovascular dysfunction: The pivotal role of endothelial CD2AP in Alzheimer's disease [J]. Neuron, 2025, 113(6): 797-800.

[37]ZHANG R, WANG H, CHENG X, et al. High estrogen induces trans-differentiation of vascular smooth muscle cells to a macrophage-like phenotype resulting in aortic inflammation via inhibiting VHL/HIF1a/ KLF4 axis [J]. Aging, 2024, 16(11): 9876-98.

[38]SINGH P, PARAMANIK V. DNA methylation, histone acetylation in the regulation of memory and its modulation during aging [J]. Frontiers in aging, 2024, 5: 1480932.

[39]SINGH P, PARAMANIK V. Neuromodulating roles of estrogen and phytoestrogens in cognitive therapeutics through epigenetic modifications during aging [J]. Front Aging Neurosci, 2022, 14: 945076.

[40]WOOD ALEXANDER M, WU C Y, COUGHLAN G T, et al. Associations Between Age at Menopause, Vascular Risk, and 3-Year Cognitive Change in the Canadian Longitudinal Study on Aging [J]. Neurology, 2024, 102(9): e209298.

[41]KEAWTEP P, SUNGKARAT S, BORIPUNTAKUL S, et al. Effects of combined dietary intervention and physical-cognitive exercise on cognitive function and cardiometabolic health of postmenopausal women with obesity: a randomized controlled trial [J]. The international journal of behavioral nutrition and physical activity, 2024, 21(1): 28.

[42]LI J, ZHANG P, YANG L. Effect of 12-week fitness walking programme on sex hormone levels and risk factors for metabolic syndrome in postmenopausal women: A pilot study [J]. Nutrition, metabolism, and cardiovascular diseases : NMCD, 2025: 103935.

[43]THURSTON R C, WU M, CHANG Y F, et al. Menopausal Vasomotor Symptoms and White Matter Hyperintensities in Midlife Women [J]. Neurology, 2023, 100(2): e133-e41.

[44] PETERSON A, GOTTESMAN R T, MILLER E C, et al. The association of vasomotor symptoms during the menopausal transition and cognition in later life [J]. Menopause, 2022, 29(7): 832-9.

[45]MOSCONI L, WILLIAMS S, CARLTON C, et al. Neurophysiological correlates of subjective cognitive decline in perimenopausal and postmenopausal midlife women at risk for Alzheimer's disease [J]. Menopause, 2025.

[46]LOGUE M W, DASGUPTA S, FARRER L A. Genetics of Alzheimer's Disease in the African American Population [J]. Journal of clinical medicine, 2023, 12(16).

[47]BEYDOUN M A, WEISS J, BANERJEE S, et al. Race, polygenic risk and their association with incident dementia among older US adults [J]. Brain communications, 2022, 4(6): fcac317.

[48]LAM J O, WHITMER R A, CORRADA M M, et al. Gender differences in the association between education and late-life cognitive function in the LifeAfter90 Study: A multiethnic cohort of the oldest-old [J]. Alzheimers Dement, 2024, 20(11): 7547-55.

[49]DURRANI R, FRIEDRICH M G, SCHULZE K M, et al. Effect of Cognitive Reserve on the Association of Vascular Brain Injury With Cognition: Analysis of the PURE and CAHHM Studies [J]. Neurology, 2021, 97(17): e1707-e16.

[50]DAVIS S R, BABER R J. Treating menopause - MHT and beyond [J]. Nature reviews Endocrinology, 2022, 18(8): 490-502.

[51]LEE J K, FRANK R D, CHRISTENSON L R, et al. Associations of reproductive factors and exogenous estrogens with global and domain-specific cognition in later life [J]. Alzheimers Dement, 2024, 20(1): 63-73.

[52]SALEH R N M, HORNBERGER M, RITCHIE C W, et al. Hormone replacement therapy is associated with improved cognition and larger brain volumes in at-risk APOE4 women: results from the European Prevention of Alzheimer's Disease (EPAD) cohort [J]. Alzheimer's research & therapy, 2023, 15(1): 10.

[53]PINES A. Alzheimer's disease, menopause and the impact of the estrogenic environment [J]. Climacteric : the journal of the International Menopause Society, 2016, 19(5): 430-2.

[54]GIRARD R, METEREAU E, THOMAS J, et al. Hormone therapy at early post-menopause increases cognitive control-related prefrontal activity [J]. Sci Rep, 2017, 7: 44917.

[55]SINHA P, RANI A, KUMAR A, et al. Examination of CA1 Hippocampal DNA Methylation as a Mechanism for Closing of Estrogen's Critical Window [J]. Front Aging Neurosci, 2021,13: 717032.

[56]KOIRE A, JOFFE H, BUCKLEY R. Menopausal Hormone Therapy and the Mind: The Role of Hormone Replacement in the Prevention and Treatment of Cognitive Decline, Dementia, and Cognitive Dysfunction of Depression [J]. Harvard review of psychiatry, 2022, 30(4): 215-25.

[57]SIMMONS N, RUIZ M R, RONCA F. Perimenopausal Physical Activity and Dementia Risk: A Systematic Review [J]. International journal of sports medicine, 2024, 45(9): 637-58.

[58]SHEN Y, SHI Q, NONG K, et al. Exercise for sarcopenia in older people: A systematic review and network meta-analysis [J]. Journal of cachexia, sarcopenia and muscle, 2023, 14(3): 1199-211.

[59]HAO Z, LIU K, QI W, et al. Which exercise interventions are more helpful in treating primary obesity in young adults? A systematic review and Bayesian network meta-analysis [J]. Archives of medical science : AMS, 2023, 19(4): 865-83.

[60]LI Y Z, LIU Y J, ZHANG W, et al. Combined treatment with valproic acid and estrogen has neuroprotective effects in ovariectomized mice with Alzheimer's disease [J]. Neural regeneration research, 2021, 16(10): 2078-85.

[61] SKOCZEK-RUBINSKA A, MUZSIK-KAZIMIERSKA A, CHMURZYNSKA A, et al. Inflammatory Potential of Diet Is Associated with Biomarkers Levels of Inflammation and Cognitive Function among Postmenopausal Women [J]. Nutrients, 2021, 13(7).

[62]ZHU C, ARUNOGIRI S, LI Q, et al. Cognitive Training During Midlife: A Systematic Review and Meta-Analysis [J]. Neuropsychol Rev, 2024.

[63]POPPE A, RITTER F D E, BAIS L, et al. The efficacy of combining cognitive training and noninvasive brain stimulation: A transdiagnostic systematic review and meta-analysis [J]. Psychological bulletin, 2024, 150(2): 192-213.

[64]YANG T, LIU W, HE J, et al. The cognitive effect of non-invasive brain stimulation combined with cognitive training in Alzheimer's disease and mild cognitive impairment: a systematic review and meta-analysis [J]. Alzheimer's research & therapy, 2024, 16(1): 140.

[65]CHLEBOWSKI R T, RAPP S, ARAGAKI A K, et al. Low-fat dietary pattern and global cognitive function: Exploratory analyses of the Women's Health Initiative (WHI) randomized Dietary Modification trial [J]. EClinicalMedicine, 2020, 18: 100240.

[66]RAZA M L, HASSAN S T, JAMIL S, et al. Nutritional interventions in depression: The role of vitamin D and omega-3 fatty acids in neuropsychiatric health [J]. Clinical nutrition (Edinburgh, Scotland), 2025, 45: 270-80.

[67]BUTLER M, NELSON V A, DAVILA H, et al. Over-the-Counter Supplement Interventions to Prevent Cognitive Decline, Mild Cognitive Impairment, and Clinical Alzheimer-Type Dementia: A Systematic Review [J]. Ann Intern Med, 2018, 168(1): 52-62.

[68]REDDAN J M, MACPHERSON H, WHITE D J, et al. Examining the relationship between nutrition and cerebral structural integrity in older adults without dementia [J]. Nutrition research reviews, 2019, 32(1): 79-98.